LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 10 of 15: Cell count and normalized growth rate inhibition values within biological replicate 3. - Dataset (ID:20247)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Hs 578T | Crizotinib | 0.04 | uM | LJP5 | 1 | A24 | 72 | hr | 658 | 3690 | 3908 | 0.9441 | 0.9557 |
Hs 578T | Crizotinib | 0.04 | uM | LJP5 | 2 | A24 | 72 | hr | 658 | 3591 | 3953 | 0.9083 | 0.9270 |
Hs 578T | Crizotinib | 0.04 | uM | LJP5 | 3 | A24 | 72 | hr | 658 | 3702 | 3938 | 0.9400 | 0.9526 |
Hs 578T | Crizotinib | 0.12 | uM | LJP5 | 1 | A23 | 72 | hr | 658 | 3483 | 3908 | 0.8911 | 0.9123 |
Hs 578T | Crizotinib | 0.12 | uM | LJP5 | 2 | A23 | 72 | hr | 658 | 3464 | 3953 | 0.8761 | 0.9003 |
Hs 578T | Crizotinib | 0.12 | uM | LJP5 | 3 | A23 | 72 | hr | 658 | 3635 | 3938 | 0.9230 | 0.9388 |
Hs 578T | Crizotinib | 0.37 | uM | LJP5 | 1 | A22 | 72 | hr | 658 | 3239 | 3908 | 0.8287 | 0.8590 |
Hs 578T | Crizotinib | 0.37 | uM | LJP5 | 2 | A22 | 72 | hr | 658 | 3413 | 3953 | 0.8632 | 0.8895 |
Hs 578T | Crizotinib | 0.37 | uM | LJP5 | 3 | A22 | 72 | hr | 658 | 3511 | 3938 | 0.8915 | 0.9129 |
Hs 578T | Crizotinib | 1.11 | uM | LJP5 | 1 | A21 | 72 | hr | 658 | 2220 | 3908 | 0.5680 | 0.6049 |
Hs 578T | Crizotinib | 1.11 | uM | LJP5 | 2 | A21 | 72 | hr | 658 | 2315 | 3953 | 0.5855 | 0.6262 |
Hs 578T | Crizotinib | 1.11 | uM | LJP5 | 3 | A21 | 72 | hr | 658 | 2512 | 3938 | 0.6378 | 0.6802 |
Hs 578T | Crizotinib | 3.33 | uM | LJP5 | 1 | A20 | 72 | hr | 658 | 933 | 3908 | 0.2387 | 0.1454 |
Hs 578T | Crizotinib | 3.33 | uM | LJP5 | 2 | A20 | 72 | hr | 658 | 896 | 3953 | 0.2266 | 0.1267 |
Hs 578T | Crizotinib | 3.33 | uM | LJP5 | 3 | A20 | 72 | hr | 658 | 974 | 3938 | 0.2473 | 0.1640 |
Hs 578T | Crizotinib | 10 | uM | LJP5 | 1 | A19 | 72 | hr | 658 | 861 | 3908 | 0.2203 | 0.1102 |
Hs 578T | Crizotinib | 10 | uM | LJP5 | 2 | A19 | 72 | hr | 658 | 893 | 3953 | 0.2259 | 0.1252 |
Hs 578T | Crizotinib | 10 | uM | LJP5 | 3 | A19 | 72 | hr | 658 | 849 | 3938 | 0.2156 | 0.1037 |
Hs 578T | BMS345541 | 0.04 | uM | LJP6 | 1 | D06 | 72 | hr | 658 | 3812 | 3705 | 1.0286 | 1.0228 |
Hs 578T | BMS345541 | 0.04 | uM | LJP6 | 2 | D06 | 72 | hr | 658 | 3974 | 3807 | 1.0437 | 1.0341 |
Hs 578T | BMS345541 | 0.04 | uM | LJP6 | 3 | D06 | 72 | hr | 658 | 3942 | 3769 | 1.0457 | 1.0358 |
Hs 578T | BMS345541 | 0.12 | uM | LJP6 | 1 | D05 | 72 | hr | 658 | 3612 | 3705 | 0.9747 | 0.9795 |
Hs 578T | BMS345541 | 0.12 | uM | LJP6 | 2 | D05 | 72 | hr | 658 | 3961 | 3807 | 1.0403 | 1.0314 |
Hs 578T | BMS345541 | 0.12 | uM | LJP6 | 3 | D05 | 72 | hr | 658 | 3720 | 3769 | 0.9868 | 0.9895 |
Hs 578T | BMS345541 | 0.37 | uM | LJP6 | 1 | D04 | 72 | hr | 658 | 3594 | 3705 | 0.9698 | 0.9756 |